RedHill Biopharma (RDHL) Posts Q3 Loss of 7c/Share

RedHill Biopharma (NASDAQ: RDHL) reported Q3 EPS of ($0.07), $0.51 better than the analyst estimate of ($0.58).

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49